Deregulation of lipid metabolism pathway genes in nasopharyngeal carcinoma cells

Molecular Medicine Reports

Volumn 7, Issue 3, 2013, Pages 731-741

  Daker, Maelinda ^a   Bhuvanendran, Saatheeyavaane ^a   Ahmad, Munirah ^a   Takada, Kenzo ^b   Khoo, Alan Soo Beng ^a  

^a INSTITUTE FOR MEDICAL RESEARCH   (Malaysia)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Epstein Barr virus encoded RNAs; Fatty acid synthase; Lipid metabolism; Low density lipoprotein receptor; Nasopharyngeal carcinoma; Quercetin

Indexed keywords

EPSTEIN BARR VIRUS ENCODED RNA; FATTY ACID SYNTHASE; LOW DENSITY LIPOPROTEIN RECEPTOR; QUERCETIN; RNA; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CARCINOMA CELL; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GROWTH RATE; LIPID METABOLISM; METABOLIC REGULATION; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; RECEPTOR UPREGULATION; STABLE EXPRESSION;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CISPLATIN; FATTY ACID SYNTHASES; GENE EXPRESSION PROFILING; HERPESVIRUS 4, HUMAN; HUMANS; LIPID METABOLISM; MICE; MICE, NUDE; NASOPHARYNGEAL NEOPLASMS; QUERCETIN; RECEPTORS, LDL; RNA, VIRAL; TRANSPLANTATION, HETEROLOGOUS; UP-REGULATION; VIRAL MATRIX PROTEINS;

EID: 84873139500     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.1253     Document Type: Article

References (42)

1. Tao Q and Chan AT: Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments. Exp Rev Mol Med 9:1-24, 2007. (Pubitemid 47398642)
2. Chou J, Lin YC, Kim J, You L, Xu Z, He B and Jablons DM: Nasopharyngeal carcinoma-review of the molecular mechanisms of tumorigenesis. Head Neck 30:946-963, 2008. (Pubitemid 352008957)
3. Takada K and Nanbo A: The role of EBERs in oncogenesis. Semin Cancer Biol 11:461-467, 2001. (Pubitemid 33105025)
4. Komano J, Maruo S, Kurozumi K, Oda T and Takada K: Oncogenic role of Epstein. Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata. J Virol 73:9827-9831, 1999.
5. Yamamoto N, Takizawa T, Iwanaga Y, Shimizu N and Yamamoto N: Malignant transformation of B lymphoma cell line BJAB by Epstein. Barr virus-encoded small RNAs. FEBS Lett 484:153-158, 2000.
6. Kitagawa N, Goto M, Kurozumi K, Maruo S, Fukayama M, Naoe T, Yasukawa M, Hino K, Suzuki T, Todo S and Takada K: Epstein. Barr virus-encoded poly (A) (.) RNA supports Burkitt's lymphoma growth through interleukin. 10 induction. EMBO J 19:6742-6750, 2000. (Pubitemid 32011667)
7. Yang L, Aozasa K, Oshimi K and Takada K: Epstein. Barr virus (EBV).encoded RNA promotes growth of EBV-infected T cells through interleukin. 9 induction. Cancer Res 64:5332-5337, 2004. (Pubitemid 39006553)
8. Wong HL, Wang X, Chang RC, et al: Stable expression of EBERs in immortalized nasopharyngeal epithelial cells confers resistance to apoptotic stress. Mol Carcinog 44:92-101, 2005. (Pubitemid 41398204)
9. Iwakiri D, Eizuru Y, Tokunaga M and Takada K: Autocrine growth of Epstein. Barr virus-positive gastric carcinoma cells mediated by an Epstein. Barr virus-encoded small RNA. Cancer Res 63:7062-7067, 2003. (Pubitemid 37413440)
10. Iwakiri D, Sheen TS, Chen JY, Huang DP and Takada K: Epstein. Barr virus-encoded small RNA induces insulin. like growth factor 1 and supports growth of nasopharyngeal carcinoma-derived cell lines. Oncogene 24:1767-1773, 2005. (Pubitemid 40461132)
11. Huang DP, Ho JH, Poon YF, Chew EC, Saw D, Lui M, Li CL, Mak LS, Lai SH and Lau WH: Establishment of a cell line (NPC/HK1) from a differentiated squamous carcinoma of the nasopharynx. Int J Cancer 26:127-132, 1980. (Pubitemid 10086410)
12. Cheung ST, Huang DP, Hui AB, Lo KW, Ko CW, Tsang YS, Wong N, Whitney BM and Lee JC: Nasopharyngeal carcinoma cell line (C666.1) consistently harbouring Epstein. Barr virus. Int J Cancer 83:121-126, 1999. (Pubitemid 29409487)
13. Chan SY, Choy KW, Tsao SW, Tao Q, Tang T, Chung GT and Lo KW: Authentication of nasopharyngeal carcinoma tumor lines. Int J Cancer 122:2169-2171, 2008. (Pubitemid 351441212)
14. Geback T, Schulz MM, Koumoutsakos P and Detmar M: TScratch: a novel and simple software tool for automated analysis of monolayer wound healing assays. Biotechniques 46:265-274, 2008.
15. Edgar R, Domrachev M and Lash AE: Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30:207-210, 2002. (Pubitemid 34679544)
16. Busson P, Ganem G, Flores P, Mugneret F, Clausse B, Caillou B, Braham K, Wakasugi H, Lipinski M and Tursz T: Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas. Int J Cancer 42:599-606, 1988. (Pubitemid 18264074)
17. Cory G: Scratch-wound assay. In: Cell Migration: Developmental Methods and Protocols, Methods in Molecular Biology. Wells CM and Parsons M (eds). Vol 769. Springer Science+Business Media, LLC, New York, NY, pp25-30, 2011.
18. Sturn A, Quackenbush J and Trajanoski Z: Genesis: cluster analysis of microarray data. Bioinformatics 18:207-208, 2002. (Pubitemid 34145055)
19. Brusselmans K, Vrolix R, Verhoeven G and Swinnen JV: Induction of cancer cell apoptosis by flavonoids is associated with their ability to inhibit fatty acid synthase activity. J Biol Chem 280:5636-5645, 2005. (Pubitemid 40280043)
20. Daker M, Ahmad M and Khoo ASB: Quercetin-induced inhibition and synergistic activity with cisplatin-a chemotherapeutic strategy for nasopharyngeal carcinoma cells. Cancer Cell Int 12:34, 2012.
21. Hirsch HA, Iliopoulos D, Joshi A, Zhang Y, Jaeger SA, Bulyk M, Tsichlis PN, Shirley Liu X and Struhl K: A transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseases. Cancer Cell 17:348-361, 2010.
22. Chung NS and Wasan KM: Potential role of the low-density lipoprotein receptor family as mediators of cellular drug uptake. Adv Drug Deliv Rev 56:1315-1334, 2004. (Pubitemid 38510476)
23. Tatidis L, Gruber A and Vitols S: Decreased feedback regulation of low density lipoprotein receptor activity by sterols in leukemic cells from patients with acute myelogenous leukemia. J Lipid Res 38:2436-2445, 1997. (Pubitemid 28028128)
24. Chen Y and Hughes-Fulford M: Human prostate cancer cells lack feedback regulation of low-density lipoprotein receptor and its regulator, SREBP2. Int J Cancer 91:41-45, 2001.
25. Sekine Y, Koike H, Nakano T, Nakajima K, Takahashi S and Suzuki K: Remnant lipoproteins induced proliferation of human prostate cancer cell, PC-3 but not LNCaP, via low density liporprotein receptor. Cancer Epidemiol 33:16-23, 2009.
26. Lum DF, McQuaid KR, Gilbertson VL and Hughes-Fulford M: Coordinate up. regulation of low-density lipoprotein receptor and cyclo-oxygenase-2 gene expression in human colorectal cells and in colorectal adenocarcinoma biopsies. Int J Cancer 83:162-166, 1999. (Pubitemid 29449091)
27. Rao KN: The significance of the cholesterol biosynthetic pathway in cell growth and carcinogenesis (review). Anticancer Res 15:309-314, 1995.
28. Gueddari N, Favre G, Hachem H, Marek E, Le Gaillard F and Soula G: Evidence for up. regulated low density lipoprotein receptor in human lung adenocarcinoma cell line A549. Biochimie 75:811-819, 1993. (Pubitemid 23337721)
29. Shiroeda O, Yamaguchi N and Kawai K: Stimulation of low density lipoprotein receptor activity by conditioned medium from a human cancer cell line. Cancer Res 47:4630-4633, 1987. (Pubitemid 17127418)
30. Shimano H: Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. Prog Lipid Res 40:439-452, 2001. (Pubitemid 32929966)
31. Weber LW, Boll M and Stampfl A: Maintaining cholesterol homeostasis: sterol regulatory element-binding proteins. World J Gastroenterol 10:3081-3087, 2004. (Pubitemid 39419863)
32. Streicher R, Kotzka J, Muller-Wieland D, Siemeister G, Munck M, Avci H and Krone W: SREBP-1 mediates activation of the low density lipoprotein receptor promoter by insulin and insulin. like growth factor.1. J Biol Chem 271:7128-7133, 1996. (Pubitemid 26104151)
33. Foretz M, Guichard C, Ferre P and Foufelle F: Sterol regulatory element binding protein. 1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc Natl Acad Sci USA: 12737-12742, 1999. (Pubitemid 29513572)
34. La Voie HA, Garmey JC, Day RN and Veldhuis JD: Concerted regulation of low density lipoprotein receptor gene expression by follicle-stimulating hormone and insulin. like growth factor 1 in porcine granulosa cells: promoter activation, messenger ribonucleic acid stability and sterol feedback. Endocrinology 140:178-186, 1999. (Pubitemid 29011158)
35. Kuhajda FP: Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition 16:202-208, 2000. (Pubitemid 30114274)
36. Menendez JA and Lupu R: Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 7:763-777, 2007. (Pubitemid 47469806)
37. Kuhajda FP: Fatty acid synthase and cancer: new application of an old pathway. Cancer Res 66:5977-5980, 2006.
38. Zhang F, Cui Y and Cao P: Effect of quercetin on proliferation and apoptosis of human nasopharyngeal carcinoma HEN1 cells. J Huazhong Univ Sci Technolog Med Sci 28:369-372, 2008.
39. Yoshida M, Sakai T, Hosokawa N, Marui N, Matsumoto K, Fujioka A, Nishino H and Aoike A: The effect of quercetin on cell cycle progression and growth of human gastric cancer cells. FEBS Lett 260:10-13, 1990. (Pubitemid 20029416)
40. Yoshida M, Yamamoto M and Nikaido T: Quercetin arrests human leukemic T-cells in late G1 phase of the cell cycle. Cancer Res 52:6676-6681, 1992.
41. Lupu R and Menendez JA: Pharmacological inhibitors of Fatty Acid Synthase (FASN)-catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents? Curr Pharm Biotechnol 7:483-493, 2006.
42. Pizer ES, Chrest FJ, Di Giuseppe JA and Han WF: Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines. Cancer Res 58:4611-4615, 1998. (Pubitemid 28480625)